oncolytic viruses

Gene Delivery
Novel Immunocompetent Murine Tumor Model for Evaluation of Conditionally Replication-Competent (Oncolytic) Murine Adenoviral Vectors
Michael Robinson, Betty Li, Ying Ge, Derek Ko, Satya Yendluri, Thomas Harding, Melinda VanRoey, Katherine R. Spindler, Karin Jooss
Transformation and Oncogenesis
E4orf1 Limits the Oncolytic Potential of the E1B-55K Deletion Mutant Adenovirus
Michael A. Thomas, Robin S. Broughton, Felicia D. Goodrum, David A. Ornelles
Gene Delivery | Spotlight
Effect of Preexisting Immunity on Oncolytic Adenovirus Vector INGN 007 Antitumor Efficacy in Immunocompetent and Immunosuppressed Syrian Hamsters
Debanjan Dhar, Jacqueline F. Spencer, Karoly Toth, William S. M. Wold
Virus-Cell Interactions
A Hyperfusogenic F Protein Enhances the Oncolytic Potency of a Paramyxovirus Simian Virus 5 P/V Mutant without Compromising Sensitivity to Type I Interferon
Maria D. Gainey, Mary J. Manuse, Griffith D. Parks
Pathogenesis and Immunity
Myxoma Virus Expressing Human Interleukin-12 Does Not Induce Myxomatosis in European Rabbits
Marianne M. Stanford, John W. Barrett, Philippe-Alexandre Gilbert, Richard Bankert, Grant McFadden
Pathogenesis and Immunity
Variable Deficiencies in the Interferon Response Enhance Susceptibility to Vesicular Stomatitis Virus Oncolytic Actions in Glioblastoma Cells but Not in Normal Human Glial Cells
Guido Wollmann, Michael D. Robek, Anthony N. van den Pol
Gene Delivery
Oncolytic Virotherapy Synergism with Signaling Inhibitors: Rapamycin Increases Myxoma Virus Tropism for Human Tumor Cells
Marianne M. Stanford, John W. Barrett, Steven H. Nazarian, Steven Werden, Grant McFadden
Pathogenesis and Immunity
Newcastle Disease Virus Exerts Oncolysis by both Intrinsic and Extrinsic Caspase-Dependent Pathways of Cell Death
Subbiah Elankumaran, Daniel Rockemann, Siba K. Samal

Pages